Xp11.2 Translocation Renal Cell Carcinoma With <i>TFE3</i> Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners.

Ge, Yan; Lin, Xingtao; Zhang, Qingling; Lin, Danyi; Luo, Luqiao; Wang, Huiling; Li, Zhi

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners.

Ge, Yan; Lin, Xingtao; Zhang, Qingling; Lin, Danyi; Luo, Luqiao; Wang, Huiling; Li, Zhi.

Afiliação

Ge Y; Department of Pathology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.
Lin X; Department of Pathology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhang Q; Department of Pathology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.
Lin D; Department of Pathology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.
Luo L; Department of Pathology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.
Wang H; Department of General Surgery, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.
Li Z; Department of Pathology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.

Front Oncol ; 11: 784993, 2021.

Article em En | MEDLINE | ID: mdl-34917511

Palavras-chave

TFE3; VCP; Xp11.2 translocation; rearrangement; renal cell carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google